Global Sjogren's Syndrome Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Sjogren's Syndrome Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Sjogren's syndrome is an autoimmune disease. This means that your immune system attacks parts of your own body by mistake. In Sjogren's syndrome, it attacks the glands that make tears and saliva. This causes a dry mouth and dry eyes. You may have dryness in other places that need moisture, such as your nose, throat, and skin. Sjogren's can also affect other parts of the body, including your joints, lungs, kidneys, blood vessels, digestive organs, and nerves.

Market Overview:

The latest research study on the global Sjogren's Syndrome market finds that the global Sjogren's Syndrome market reached a value of USD 888.2 million in 2022. It’s expected that the market will achieve USD 1316.71 million by 2028, exhibiting a CAGR of 6.78% during the forecast period.

Company Overview:

Allergan Inc is one of the major players operating in the Sjogren's Syndrome market, holding a share of 10.83% in 2019.

Segmentation Overview:

Among different product types, Cyclosporine segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Eye Care segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Sjogren's Syndrome market covered in Chapter 3:

Otsuka Holdings Co., Ltd.
Novartis International AG
arGentis Pharmaceuticals, LLC
Daiichi Sankyo
Biogen
Allergan Inc
Eisai Co., Ltd.
AstraZeneca
Kissei Pharmaceutical Co., Ltd.
Genentech, Inc.
Pfizer Inc.
Ono Pharmaceutical
Amgen
F. Hoffmann-La Roche AG
Nicox S.A
Astellas Pharma Inc.
Santen Pharma
Bristol-Myers Squibb

In Chapter 4 and Chapter 14.2, on the basis of types, the Sjogren's Syndrome market from 2018 to 2029 is primarily split into:

Primary Sjogren Syndrome
Secondary Sjogren Syndrome

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Sjogren's Syndrome market from 2018 to 2029 covers:

Hospitals
Clinical Laboratories
Pharmacies
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)